| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/03/2013 | WO2012155226A8 Method for producing pyrostegia venusta derivatives, pyrostegia venusta derivatives, pharmaceutical compositions and uses thereof |
| 01/03/2013 | WO2012154311A3 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing |
| 01/03/2013 | WO2012148720A3 Anti-microbial peptides and methods of use thereof |
| 01/03/2013 | WO2012145680A3 Anti-microbial peptides and uses therefore |
| 01/03/2013 | WO2012140127A3 Method for priming of t cells |
| 01/03/2013 | WO2012137227A3 Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof |
| 01/03/2013 | WO2012135615A3 Enopeptins, uses thereof, and methods of synthesis thereto |
| 01/03/2013 | WO2012135296A3 Imidazolyl amide compounds and uses related thereto |
| 01/03/2013 | WO2012135027A3 Thiolactone antibiotics |
| 01/03/2013 | WO2009095796A3 Tapasin augmentation for enhanced immune response |
| 01/03/2013 | US20130006182 Pharmaceutical compositions |
| 01/03/2013 | US20130005836 Composition and methods related to s100 a2 |
| 01/03/2013 | US20130005829 Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom |
| 01/03/2013 | US20130005804 Novel Uses of Neuraminidase Inhibitors in Infectious Diseases |
| 01/03/2013 | US20130005793 Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus |
| 01/03/2013 | US20130005792 Biomarkers to identify hiv-specific t-cell subsets |
| 01/03/2013 | US20130005791 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 01/03/2013 | US20130005788 Anti-francisella agents |
| 01/03/2013 | US20130005787 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 01/03/2013 | US20130005785 Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations |
| 01/03/2013 | US20130005776 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005760 Heterocyclic compound having azole group |
| 01/03/2013 | US20130005759 Small molecule modifiers of microrna mir-122 |
| 01/03/2013 | US20130005758 Manufacture, method and use of drug-eluting medical devices for permanently keeping blood vessels open |
| 01/03/2013 | US20130005752 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005748 Compounds and compositions as protein kinase inhibitors |
| 01/03/2013 | US20130005740 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
| 01/03/2013 | US20130005736 Antiviral agents |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005713 Process for Preparing Diaminophenothiazinium Compounds |
| 01/03/2013 | US20130005707 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith |
| 01/03/2013 | US20130005694 Liquid compositions comprising vitamin d and uses thereof |
| 01/03/2013 | US20130005690 S-nitrosylation of glucosylating toxins and uses therefor |
| 01/03/2013 | US20130005677 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
| 01/03/2013 | US20130005674 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| 01/03/2013 | US20130005673 Extracts From Kibdelos Porangium As Antibacterial Agents |
| 01/03/2013 | US20130005669 Novel synthetic glycolipid and use thereof |
| 01/03/2013 | US20130005660 Plasma Activation of Biological Materials for Surface Modification |
| 01/03/2013 | US20130005648 Peptide compositions and methods for inhibiting herpesvirus infection |
| 01/03/2013 | US20130005647 Mutant nisin ser 29 derivatives and the use thereof |
| 01/03/2013 | US20130004651 Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials |
| 01/03/2013 | US20130004594 Oral rehydration composition |
| 01/03/2013 | US20130004591 Formulation for relief of cold and flu symptoms |
| 01/03/2013 | US20130004586 Biologically Efficacious Compositions, Articles of Manufacture and Processes for Producing and/or Using Same |
| 01/03/2013 | US20130004585 Method Of Manufacturing Antimicrobial Implants Of Polyetheretherketone |
| 01/03/2013 | US20130004578 Solid Pharmaceutical Dosage Formulation |
| 01/03/2013 | US20130004576 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 01/03/2013 | US20130004569 Oral antimicrobial pharmaceutical compositions |
| 01/03/2013 | US20130004564 Antimicrobial peptides |
| 01/03/2013 | US20130004561 Therapies for preventing or suppressing clostridium difficile infection |
| 01/03/2013 | US20130004557 Antimicrobial Resin Compositions |
| 01/03/2013 | US20130004544 Synthetic Antibacterial Clay Compositions and Method of Using Same |
| 01/03/2013 | US20130004539 Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
| 01/03/2013 | US20130004535 Multiple vaccination including serogroup c meningococcus |
| 01/03/2013 | US20130004534 Inactivation of reverse transcriptases by azido-diarylpyrimidines |
| 01/03/2013 | US20130004531 Immunogens from uropathogenic escherichia coli |
| 01/03/2013 | US20130004530 Vaccine composition |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004510 Vaccine |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004505 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 01/03/2013 | US20130004502 Influenza targets |
| 01/03/2013 | US20130004500 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004499 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004497 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004496 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004476 Chimeric Polypeptides and Their Use in Bacterial Decolonization |
| 01/03/2013 | US20130004473 Methods and Biomarkers for the Detection of Dengue Hemorrhagic Fever |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004458 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 01/03/2013 | US20130004457 Hepatitis C Virus Inhibitors |
| 01/03/2013 | US20130004434 Gastroretentive, Extended Release Composition Of Therapeutic Agent |
| 01/03/2013 | US20130004425 Biomineral and Metal Binding Liposomes, Their Synthesis, and Methods of Use Thereof |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | CA2840681A1 Location-specific bacterial management |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840571A1 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 01/03/2013 | CA2840540A1 Prevention and treatment of hiv infection |
| 01/03/2013 | CA2840060A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | CA2839668A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2833778A1 Compositions and methods for inhibiting gene expression of hepatitis b virus |
| 01/02/2013 | EP2540821A1 Method for producing regulatory dendritic cells |
| 01/02/2013 | EP2540818A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
| 01/02/2013 | EP2540720A1 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
| 01/02/2013 | EP2540717A1 Lamivudine oxalate and preparation method thereof |
| 01/02/2013 | EP2540350A1 Combinations of a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitors with other HCV agents |
| 01/02/2013 | EP2540349A1 Pharmaceutical compositions comprising a macrocyclic quinoxaline compound which is an HCV NS3 protease inhibitor |
| 01/02/2013 | EP2540307A1 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 01/02/2013 | EP2540299A1 Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof |
| 01/02/2013 | EP2539365A2 Method of inducing the production of protective anti-hiv-1 antibodies |
| 01/02/2013 | EP2539348A1 Cephalosporin derivatives useful as -lactamase inhibitors and compositions and methods of use thereof |
| 01/02/2013 | EP2539341A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b][1.4]diazepine-2.4-dione as inhibitors of hiv replication |
| 01/02/2013 | EP2539340A1 Pyrazolopyridazine derivatives for the treatment of hepatitis c |
| 01/02/2013 | EP2539310A1 Synthesis of magnolol and its analogue compounds |
| 01/02/2013 | EP2538971A1 Combination vaccine for streptococcus |
| 01/02/2013 | EP2538946A1 Anti-viral formulations |
| 01/02/2013 | EP2538938A1 Fungal nail treatment composition |
| 01/02/2013 | CN202637533U Compound bismuth potassium citrate capsule |